Tlr4: Central component of the sole mammalian LPS sensor

Current Opinion in Immunology

Volumn 12, Issue 1, 2000, Pages 20-26

  Beutler, Bruce ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18 RECEPTOR; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; PHOSPHOTRANSFERASE; RECEPTOR; TOLL RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; GENE LOCUS; GENE MUTATION; HUMAN; MOUSE; NONHUMAN; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033952703     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00046-1     Document Type: Review

References (50)

1. Janeway C.A. Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today. 13:1992;11-16.
2. Sultzer B.M. Genetic control of leucocyte responses to endotoxin. Nature. 219:1968;1253-1254.
3. Watson J., Riblet R., Taylor B.A. The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J Immunol. 118:1977;2088-2093.
4. Coutinho A., Meo T. Genetic basis for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Immunogenetics. 7:1978;17-24.
5. O'Brien A.D., Rosenstreich D.L., Scher I., Campbell G.H., Macdermott R.P., Formal S.B. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol. 124:1980;20-24.
6. Rosenstreich D.L., Weinblatt A.C., O'Brien A.D. Genetic control of resistance to infection in mice. CRC Crit Rev Immunol. 3:1982;263-330.
7. Michalek S.M., Moore R.N., McGhee J.R., Rosenstreich D.L., Mergenhagen S.E. The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxin. J Infect Dis. 141:1980;55-63.
8. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
9. Watson J., Kelly K., Largen M., Taylor B.A. The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol. 120:1978;422-424.
10. Qureshi S.T., Lariviere L., Sebastiani G., Clermont S., Skamene E., Gros P., Malo D. A high-resolution map in the chromosomal region surrounding the Lps locus. Genomics. 31:1996;283-294.
11. Poltorak A., Smirnova I., He X.L., Liu M-Y., Van Huffel C., Birdwell D., Alejos E., Silva M., Du X., Thompson P.et al. Genetic and physical mapping of the Lps locus- identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis. 24:1998;340-355. A higher-resolution genetic map, combined with gene identification data revealing that TlR4 is the sole candidate gene in a critical region.
12. Poltorak A., He X., Smirnova I., Liu M-Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C.et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TlR4 gene. Science. 282:1998;2085-2088. The critical demonstration of mutations in Tlr4 that are responsible for LPS insensitivity in C3H/HeJ mice and C57BL/10ScCr mice.
13. Anderson K.V., Jurgens G., Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell. 42:1985;779-789.
14. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 86:1996;973-983.
15. Belvin M.P., Anderson K.V. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol. 12:1996;393-416.
16. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA. 95:1998;588-593.
17. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll, protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
18. Wasserman S.A. A conserved signal transduction pathway regulating the activity of the rel-like proteins dorsal and NF-kappa B. Mol Biol Cell. 4:1993;767-771.
19. Muzio M., Natoli G., Saccani S., Levrero M., Mantovani A. The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med. 187:1998;2097-2101.
20. Medzhitov R., Preston-Hurlburt P., Koppe E., Stadlen A., Chen C., Ghosh S., Janeway C.A. Jr. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell. 2:1998;253-258.
21. Williams M.J., Rodriguez A., Kimbrell D.A., Eldon E.D. The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J. 16:1997;6120-6130.
22. Rosenstreich D.L., Vogel S.N., Jacques A.R., Wahl L.M., Oppenheim J.J. Macrophage sensitivity to endotoxin. Genetic control by a single codominant gene. J Immunol. 121:1978;1664-1670.
23. Muller H.J. Evidence of the precision of genetic adaptation. Harvey Lectures. 43:1948;165-229.
24. Du X., Poltorak A., Silva M., Beutler B. Mutational analysis of Tlr4-mediated LPS signal transduction in macrophages. Blood Cells Mol Dis. 25:1999;328-338.
25. Yang R-B., Mark M.R., Gray A., Huang A., Xie M.H., Zhang M., Goddard A., Wood W.I., Gurney A.L., Godowski P.J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 395:1998;284-288.
26. Kirschning C.J., Wesche H., Merrill A.T., Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med. 188:1998;2091-2097.
27. Modlin R.L., Brightbill H.D., Godowski P.J. The toll of innate immunity on microbial pathogens. N Engl J Med. 340:1999;1834-1835.
28. Heine H., Kirschning C.J., Lien E., Monks B.G., Rothe M., Golenbock D.T. Cutting edge: cells that carry a null allele for toll-like receptor 2 are capable of responding to endotoxin. J Immunol. 162:1999;6971-6975.
29. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity. 11:1999;443-451.
30. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 162:1999;3749-3752. Confirmation that mutations at the Tlr4 locus in mice produce a phenocopy of the naturally occurring Lps mutations observed in C3H/HeJ and C57BL/ 10ScCr mice.
31. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4. J Exp Med. 189:1999;1777-1782.
32. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem. 274:1999;17406-17409.
33. Hirschfeld M., Kirschning C.J., Schwandner R., Wesche H., Weis J.H., Wooten R.M., Weis J.J. Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol. 163:1999;2382-2386.
34. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T.et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 285:1999;732-736.
35. Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D., Klimpel G.R., Godowski P., Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science. 285:1999;736-739.
36. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol. 163:1999;1-5.
37. Beutler B., Tkacenko V., Milsark I.W., Krochin N., Cerami A. The effect of interferon-γ on cachectin expression by mononuclear phagocytes: reversal of the lps-d (endotoxin resistance) phenotype. J Exp Med. 164:1986;1791-1796.
38. Beutler B., Krochin N., Milsark I.W., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 232:1986;977-980.
39. Mathison J.C., Virca G.D., Wolfson E., Tobias P.S., Glaser K., Ulevitch R.J. Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest. 85:1990;1108-1118.
40. Kirkland T.N., Virca G.D., Kuus-Reichel T., Multer F.K., Kim S.Y., Ulevitch R.J., Tobias P.S. Identification of lipopolysaccharide-binding proteins in 70Z/3 cells by photoaffinity cross-linking. J Biol Chem. 265:1990;9520-9525.
41. Han J., Lee J-D., Tobias P.S., Ulevitch R.J. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem. 268:1993;25009-25014.
42. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., Goyert S.M. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity. 4:1996;407-414.
43. Wright S.D. Toll, a new piece in the puzzle of innate immunity. J Exp Med. 189:1999;605-609.
44. Poltorak A., Ricciardi-Castagnoli P., Citterio A., Beutler B. Physical contact between LPS and Tlr4 revealed by genetic complementation. Proc Natl Acad Sci USA. 2000;. in press. By complementing the defect in C3H/HeJ macrophages using either human or murine Tlr4, the authors show that Tlr4 itself discriminates between LPS partial structures, and therefore may be presumed to have contact with LPS.
45. Golenbock D.T., Hampton R.Y., Qureshi N., Takayama K., Raetz C.R. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem. 266:1991;19490-19498.
46. Berczi I., Bertok L., Bereznai T. Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. Can J Microbiol. 12:1966;1070-1071.
47. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122. Knockout of MyD88 gene supports a critical role for MyD88 in LPS signalling, yet also reveals that it is not the sole factor.
48. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9:1998;143-150. Knockout of the MyD88 gene prevents signal transduction through the IL-1 and IL-18 receptors, suggesting that homotypic interaction between the Toll-like domain of MyD88 and receptors bearing a similar motif may be required for a biological response. Subsequently (see [49]), the observation was generalized to encompass signaling via the LPS receptor, Tlr4.
49. Kuhns D.B., Long P.D., Gallin J.I. Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections. J Immunol. 158:1997;3959-3964.
50. Frantz S., Kobzik L., Kim Y.D., Fukazawa R., Medzhitov R., Lee R.T., Kelly R.A. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest. 104:1999;271-280.